SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS shares fell sharply on heavy volume without a clear company-specific update, as traders debated whether broader biotech weakness and options-expiration dynamics contributed to the selloff. The main focus remains the pending REGAL Phase 3 milestone and data, with bullish holders viewing the delay in reaching the 80th event as potentially encouraging while skeptics cite the prolonged quiet period as a source of concern.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Reports of plague and respiratory-virus outbreaks have prompted speculation that Arcturuss self-amplifying mRNA platform could be relevant to future vaccines, with some traders pointing to its COVID-vaccine technology and discussing a possible plague vaccine. No new ARCT program or outbreak-related deal is confirmed, and the discussion also includes frustration over the share-price decline.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereums pullback and recent underperformance versus Bitcoin are driving discussion, with traders focused on whether support will hold amid broader crypto weakness and macro concerns. Sentiment is split between calls for further downside and views that the dip is a bear trap or buying opportunity.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

A rebound in long Treasuries as yields eased has drawn attention to TLT, with traders pointing to risk-off demand, Fed-rate expectations and possible short covering even as inflation remains a concern. The community is split between those seeing a lasting bond recovery and those viewing it as a temporary bounce, with sticky inflation and further rate hikes cited as risks.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds sharp correction amid hotter inflation, rising Treasury yields and a stronger dollar is the main focus, as traders debate whether the pressure will persist or the pullback has created a buying opportunity. Some also point to easing yields and dollar weakness as support for a recovery in precious metals.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereums sharp rebound and breakout are driving attention, with bullish traders citing renewed crypto momentum and institutional adoption; others remain cautious about volatility, thin volume, and overleveraged positions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTXs prolonged selloff has traders weighing disappointment with IZAR-1 results and doubts about managements plan to commercialize sonelokimab independently against the companys filed FDA application for hidradenitis suppurativa. Discussion remains split between concerns about regulatory and commercial risks and bullish views that the drug, cash balance, and broader pipeline support the long-term case.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos prolonged selloff amid fears that Eli Lilly is gaining ground in obesity drugs and doubts about Novos pipeline and management dominates discussion. Traders are divided over whether Wegovy-pill momentum and the stocks low valuation can support a recovery; many remain bearish despite positive pill data.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is drawing attention amid a sharp selloff across AI data-center and former bitcoin-miner stocks, with traders pointing to financing and higher-yield concerns, execution risks, and pressure on AI-infrastructure valuations. The community is split between calling the decline an overreaction and buying the dip versus expecting further losses as the sector weakens.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp neocloud and AI-infrastructure selloff as traders worry that rising financing costs and heavy capital needs could pressure the sector, with CoreWeaves debt concerns adding to the strain. The community is split between seeing NBIS as unfairly dragged down despite its comparatively stronger balance sheet and fearing a broader valuation reset.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is VivoPower Stock Up 30% Today?

VivoPower PLC (NASDAQ: VIVO) shares are trading sharply higher Wednesday afternoon as investors react to a pair of recent company moves aimed at reducing dilution and tightening the stock's publicly tradable float.read more...

VIVO Stock Jumps 20%, Hits 100-DMA For First Time In A Month – What’s Driving The Momentum?

Equity

VivoPower said that it has terminated its Form F-3 registration statement, originally filed on Dec. 23, 2025, to raise up to $180 million through a mix of securities.

Meridian Bioscience Achieves IVDR Certification for Alethia Molecular Assay Portfolio

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia molecular assays has...

VivoPower Plc focuses on developing and operating sustainable data center infrastructure that guarantees sovereign control over power, data, and national intelligence. It helps sovereign nations bridge the gap between their energy assets and their AI ambitions by providing the Power-to-X infrastructure necessary to build and control domestic intelligence hubs. The company operates globally with a presence across the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia. VivoPower was founded in 2014 and is headquartered in London, the United Kingdom.

VivoPower PLC. - Ordinary Shares - Class A

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.10
Prev Close	$2.36
Open	$2.36
Dividend Yield	N/A
50-Day Moving Average	$3.80
Beta	1.53
Avg. Volume	346,603.44
PE Ratio	N/A

52-Week High	$6.86
52-Week Low	$1.20
Market Capitalization	$75.34M
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VIVO Fundamentals